{"topic_id":"cn_moa_ann871_new_veterinary_drugs_pet","category":"cn-2026-approvals","context":"---\ntopic_id: cn_moa_ann871_new_veterinary_drugs_pet\ncategory: cn-2026-approvals\ntitle: \"China MOA Announcement No. 871 (January 3, 2025) — 6 New Veterinary Drug Approvals (Cefovecin Sodium / Myclobutanil Ointment / Mink CDV Vaccine etc.)\"\nlang: en\nsource: \"moa-announcement-871-20250106.html (MOA agri.cn, 102 KB, downloaded 2026-07-21)\"\ndate_parsed: 2026-07-21\ntokens_estimated: 950\nverification:\n  method: substring_match\n  claims: 8\n  passed: 8\n  date: 2026-07-21\n---\n\n# China MOA Announcement No. 871 (January 3, 2025) — 6 New Veterinary Drug Approvals\n\n中华人民共和国农业农村部公告 第 871 号 (MOA Announcement No. 871), issued **2025-01-03**, published on the MOA official information portal on 2025-01-06.\n\n## Core Provision\n\nPer the **《兽药管理条例》** (Regulations on Veterinary Drug Administration) and **《兽药注册办法》** (Measures for the Registration of Veterinary Drugs), the Ministry reviewed and **approved 6 veterinary drug products as new veterinary drugs**, applied by 20 organizations, and issued **《新兽药注册证书》** (New Veterinary Drug Registration Certificates), with published product quality standards, manufacturing process specifications, package inserts and labels, effective from the publication date.\n\n## The 6 New Veterinary Drugs\n\n| # | New veterinary drug | 研制单位 (Developers) | Class | New Veterinary Drug Certificate No. | Monitoring period | Notes |\n|---|---|---|---|---|---|---|\n| 1 | **头孢维星钠** (Cefovecin Sodium) | 齐鲁晟华制药有限公司、广东温氏大华农生物科技有限公司动物保健品厂、内蒙古联邦动保药品有限公司、天津市中升挑战生物科技有限公司、重庆医药高等专科学校、齐鲁动物保健品有限公司 | 二类 (Class 2) | （2025）新兽药证字 1 号 | 4 年 (4 years) | / |\n| 2 | **注射用头孢维星钠** (Cefovecin Sodium for Injection) | 齐鲁动物保健品有限公司、广东温氏大华农生物科技有限公司动物保健品厂、内蒙古联邦动保药品有限公司、天津市中升挑战生物科技有限公司、重庆医药高等专科学校 | 二类 (Class 2) | （2025）新兽药证字 2 号 | 4 年 | / |\n| 3 | **牛支原体灭活疫苗（CO 株）** (Bovine Mycoplasma Inactivated Vaccine, CO strain) | 北京生泰尔科技股份有限公司、北京华夏兴洋生物科技有限公司、生泰尔（内蒙古）科技有限公司 | 二类 (Class 2) | （2025）新兽药证字 3 号 | 4 年 | / |\n| 4 | **蒿板青颗粒** (Artemisia–Isatis Granules) | 中国农业大学、烟台海研制药有限公司、潍坊华英生物科技有限公司、山东德州神牛药业有限公司 | 三类 (Class 3) | （2025）新兽药证字 4 号 | 3 年 | / |\n| 5 | **鸡新城疫、禽流感（H9 亚型）、禽腺病毒（I 群，4 型）三联灭活疫苗（N7a 株+HF 株+Fiber-2 蛋白）** (Newcastle Disease + Avian Influenza H9 + Fowl Adenovirus Group I Serotype 4 Trivalent Inactivated Vaccine) | 普莱柯生物工程股份有限公司、洛阳惠中生物技术有限公司 | 三类 (Class 3) | （2025）新兽药证字 5 号 | 3 年 | / |\n| 6 | **米氮平软膏** (Mirtazapine Ointment) | 南京朗博特动物药业有限公司、江苏朗博特动物药品有限公司、湖北回盛生物科技有限公司、河北远征药业有限公司、南京乐宠乐家生物制药有限公司 | 五类 (Class 5) | （2025）新兽药证字 6 号 | 3 年 | **列入兽用处方药目录** (Listed in the Veterinary Prescription Drug Catalog) |\n\n## Veterinary Drugs with Pet-Animal Relevance\n\nAmong the 6, the following have **direct or indirect pet-animal use relevance**:\n\n- **米氮平软膏 (Mirtazapine Ointment, #6)** — an appetite stimulant and anti-nausea topical widely used in companion animal practice (dogs and cats) for management of anorexia and weight loss. The MOA registration path is Class 5 (generic / off-patent), monitoring period 3 years, and explicitly **listed in the Veterinary Prescription Drug Catalog** (兽用处方药目录), confirming prescription-only dispensing for veterinary use.\n\n## Source\n\n`pdf-raw/cn-approvals/moa-announcement-871-20250106.html` (MOA 农业农村信息网 `http://www.agri.cn/zx/hxgg/202501/t20250106_8703900.htm`, downloaded 2026-07-21, 102 KB). All 8 verified claims substring-matched against the announcement text including the developer company names, certificate numbers, drug classes and monitoring periods.\n\nFor related pet-veterinary-drug announcements in 2026, see companion topics `cn_moa_ann1022_new_veterinary_drugs_pet` (May 2026, fluralaner drops) and `cn_moa_ann1026_new_veterinary_drugs_pet` (June 2026, canine distemper antiserum + itraconazole ointment).","sources":[],"tokens_estimated":950,"generated_at":null,"tip":"Use /api/v1/topics to discover more topics. /api/v1/nutrient for precise single-point queries. /api/v1/cross_compare for 2-3 standard comparisons."}